Response: Re: Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: A modeling analysis

Daniel F. Hayes, Vered Stearns, James Rae, David Flockhart

Research output: Contribution to journalLetter

Fingerprint Dive into the research topics of 'Response: Re: Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: A modeling analysis'. Together they form a unique fingerprint.